Cargando…
Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).
2,3,5-Trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504), an inhibitor of 5-lipoxygenase and thromboxane A2 synthase and a scavenger of active oxygen species, has been shown to exhibit profound anti-tumour activity against three established murine adenocarcinomas (MACs) that are generally refra...
Autores principales: | Hussey, H. J., Bibby, M. C., Tisdale, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074504/ https://www.ncbi.nlm.nih.gov/pubmed/8630277 |
Ejemplares similares
-
Mechanism of the anti-tumour effect of 2,3,5-trimethyl-6-(3-pyridylmethyl) 1,4-benzoquinone (CV-6504).
por: Hussey, H. J., et al.
Publicado: (1997) -
Metabolism and pharmacokinetics of the anti-tumour agent 2,3,5-trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504).
por: Hussey, H. J., et al.
Publicado: (1996) -
2,3,5-Trimethyl-1,4-hydroquinone
por: Dai, Jun, et al.
Publicado: (2010) -
4-Amino-2,3,5-trimethylpyridine monohydrate
por: Dai, Li-Yan, et al.
Publicado: (2009) -
Establishment of a zebrafish hematological disease model induced by 1,4-benzoquinone
por: Zhang, Ao, et al.
Publicado: (2019)